Study of Escitalopram in the Treatment of Specific Phobia
This pilot study is designed to assess the efficacy of escitalopram in the treatment of specific phobia in adult outpatients.
|Study Design:||Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
|Official Title:||Placebo-Controlled Pilot Study of Escitalopram in the Treatment of Specific Phobia|
- Response based on a criterion of 50% or greater reduction in the Marks Main Phobia Questionnaire and Marks Fear Questionnaire from baseline
- Response based on CGI-I category
|Study Start Date:||September 2002|
|Estimated Study Completion Date:||September 2004|
This double-blind placebo-controlled pilot trial study is designed to assess the efficacy of 12 weeks of escitalopram vs. placebo in the treatment of specific phobia in adult outpatients. It is hypothesized that escitalopram is safe and effective in the treatment of specific phobia.
|United States, North Carolina|
|Dept of Psychiatry and Behvaioral Science, Duke Unviersity Medical Center|
|Durham, North Carolina, United States, 27710|
|Principal Investigator:||Kathryn M. Connor, M.D.||Duke University|